Clinically relevant differences between assays for von Willebrand factor activity-Reference-Cited by-同舟云学术

Clinically relevant differences between assays for von Willebrand factor activity

Published:2018-11-20 Issue:12 Volume:16 Page:2413-2424
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J Thromb Haemost

Author:

Boender J.¹,Eikenboom J.²³^ORCID,van der Bom J. G.⁴⁵,Meijer K.⁶,de Meris J.⁷,Fijnvandraat K.⁸⁹,Cnossen M. H.¹⁰,Laros-van Gorkom B. A. P.¹¹,van Heerde W. L.¹¹,Mauser-Bunschoten E. P.¹²,de Maat M. P. M.¹,Leebeek F. W. G.¹,

Affiliation:

1. Hematology; Erasmus University Medical Center; Rotterdam the Netherlands

2. Internal Medicine, Division; Thrombosis and Hemostasis; Leiden University Medical Center; Leiden the Netherlands

3. Einthoven Laboratory for Vascular and Regenerative Medicine; Leiden University Medical Center; Leiden the Netherlands

4. Clinical Epidemiology; Leiden University Medical Center; Leiden the Netherlands

5. Sanquin Research; Jon J van Rood Center for Clinical Transfusion Medicine; Leiden the Netherlands

6. Hematology; University of Groningen; University Medical Center Groningen; Groningen the Netherlands

7. Netherlands Hemophilia Society; Nijkerk the Netherlands

8. Pediatric Hematology; Emma Children's Hospital; Academic Medical Center; Amsterdam the Netherlands

9. Department of Plasma Proteins; Sanquin Research; Amsterdam the Netherlands

10. Pediatric Hematology; Erasmus University Medical Center - Sophia Children's Hospital; Rotterdam the Netherlands

11. Hematology; Radboud University Medical Center; Nijmegen the Netherlands

12. University Medical Center Utrecht; van Creveld Kliniek, University Utrecht; Utrecht the Netherlands

Funder

Dutch Hemophilia Foundation (Stichting Haemophilia)

CSL Behring (unrestricted grant)

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jth.14319/fullpdf

Reference27 articles.

1. von Willebrand's disease;Leebeek;N Engl J Med,2016

2. Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor;Sadler;J Thromb Haemost,2006

3. von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA);Nichols;Haemophilia,2008

4. Ristocetin-a new tool in the investigation of platelet aggregation;Howard;Thromb Diath Haemorrh,1971

5. Ristocetin: a means of differentiating von Willebrand's disease into two groups;Howard;Blood,1973

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of a 1:1 ratio VWF/FVIII concentrate in patients with von Willebrand disease;Haemophilia;2024-07-15

2. Early Postoperative Changes in Von Willebrand Factor Activity Are Associated With Future Bleeding and Stroke in HeartMate 3 Patients;ASAIO Journal;2024-06-18

3. Evaluation of an automated von Willebrand factor glycoprotein IbM activity assay compared with 3 alternative von Willebrand factor activity assays;Research and Practice in Thrombosis and Haemostasis;2024-05

4. Guideline for laboratory diagnosis and monitoring of von Willebrand disease: A joint guideline from the United Kingdom Haemophilia Centre Doctors' Organisation and the British Society for Haematology;British Journal of Haematology;2024-03-26

5. Bleeding Disorder of Unknown Cause: A Diagnosis of Exclusion;Hämostaseologie;2024-02-27